Orchidia Pharmaceuticals

Orchidia Pharmaceuticals Industries (OPI) is the sole local branded pharmaceutical player specialized in the ophthalmic segment in Egypt. Initially a service provider to multinational companies, Orchidia transformed itself into a full-fledged ophthalmologic player, successfully and advantageously competing with multinational companies such as Novartis and commanding the second market share.
-
Country:
Egypt
-
Fund:
Intaj II
-
Date:
January 2013
-
Fund shareholding:
Significant minority stake
-
Sector:
Pharmaceuticals
-
Exit date:
Exited in December 2017
Share project
Open Website
